Clinical trial registry record

Metformin Immunotherapy in HIV Infection

A registered PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Registry ID
NCT02659306
Last registry update
March 14, 2023
Status
Completed
Phase
PHASE1
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Enrollment
22
Countries
Canada
Match confidence
80%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record matched · 80% confidence

Published automatically with 80% topic confidence after controlled-term evaluation.

  • Metformin · 80%Legacy trial evaluated automatically against controlled title, summary, and longevity-context rules.

Source quality 100% · freshness 50%. These are automated routing signals, not medical or evidence-strength ratings.